Karuna Therapeutics Revenue, Growth & Competitor Profile

DBA KARUNA PHARMACEUTICALS

Company Profile & Annual Report for Karuna Therapeutics

Access the complete profile.

Karuna Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	33 Arch Street, Suite 3110 26th Floor Boston, MA 02110

Note: Revenues for privately held companies are statistical evaluations.


Karuna Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Karuna Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Karuna Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Karuna Therapeutics Annual Revenue and Growth Rate

Karuna Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Karuna Therapeutics's revenues are gauged from an analysis of company filings.

Karuna Therapeutics's Income Statement (based on Industry Averages)

Karuna Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Karuna Therapeutics is developing and marketing. Karuna Therapeutics doesn't have any recent trademark applications, indicating Karuna Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
COBENFY prescription medications for the treatment of neuropsychiatric disorders	03/28/2022
NEUBENIFY prescription medications for the treatment of neuropsychiatric disorders	11/17/2020
NEUXENTRO prescription medications for the treatment of neuropsychiatric disorders	11/17/2020

See all trademarks and details in the Full Report.

Market Share of Karuna Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Karuna Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Karuna Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Future Competition: Karuna Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Karuna Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)